Cochrane Evidence Synthesis and Methods ►

Third-line systemic chemotherapy for small cell lung cancer

To assess the effectiveness and safety of third-line chemotherapy in patients with small cell lung cancer (SCLC), compared to conventional supportive care.

This is a protocol.

Health topics:

Cancer > Lung > General aspects of treatment

Cancer > Lung > Small cell

Lungs & airways > Lung cancer > General aspects of treatment

Lungs & airways > Lung cancer > Small cell

Published:

7 May 2018

Authors:

Ikegaki S, Matsumoto H, Kataoka Y, Hirano K, Tsujimoto H, Nakata Y, Katsura M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Ikegaki S, Matsumoto H, Kataoka Y, Hirano K, Tsujimoto H, Nakata Y, Katsura M. Third-line systemic chemotherapy for small cell lung cancer. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No.: CD013025. DOI: 10.1002/14651858.CD013025